Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-03EMA Authorised: Sotyktu (deucravacitinib) — Bristol-Myers Squibb Pharma EEIG
EMEA authorises Sotyktu (deucravacitinib) for its indication in psoriasis, marking a new approved therapy in the EU.
-
EMA approval · 2026-04-24EMA Authorised: Stelara (ustekinumab) — Janssen-Cilag International NV
The EMA has authorised Stelara (ustekinumab) in the EU for psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Daxxin Psoriasis Shampoo PMCF [NA]
The post-marketing confirmatory trial of Daxxin Psoriasis Shampoo for scalp psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
An NHLBI-sponsored clinical trial update reports the completion of the Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (P…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Sebum Metabolomics and Lipidomics for Clinical Applications [NA]
Clinical trial registry entry for a study on sebum metabolomics and lipidomics for clinical applications, sponsored by National Taiwan Unive…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-04-23EMA Authorised: Taltz (ixekizumab) — Eli Lilly and Company (Ireland) Limited
EMA authorised Taltz (ixekizumab) from Eli Lilly for psoriasis, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthri…
-
EMA approval · 2026-04-23EMA Authorised: Remsima (infliximab) — Celltrion Healthcare Hungary Kft.
EMA authorised Remsima (infliximab) from Celltrion Healthcare Hungary Kft. for multiple inflammatory diseases including rheumatoid arthritis…
-
EMA approval · 2026-04-23EMA Authorised: Amgevita (adalimumab) — Amgen Europe B.V.
EMA has authorised Amgevita (adalimumab) by Amgen Europe B.V., a biosimilar of adalimumab, for multiple inflammatory diseases including rheu…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome [Phase 4]
Phase 4 trial comparing secukinumab 300 mg with a lifestyle intervention versus secukinumab alone in adults with moderate-to-severe psoriasi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL. [Phase 2]
Phase 2 randomized controlled trial evaluating roflumilast for flexural (inverse/intertriginous) and genital psoriasis; the study is current…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
FDA approval · 2026-04-17FDA Approved: CALCIPOTRIENE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved a supplemental application for CALCIPOTRIENE from Glenmark Pharmaceuticals, indicating an approved update to the existing ANDA …
-
EMA approval · 2026-04-16EMA Authorised: Steqeyma (ustekinumab) — Celltrion Healthcare Hungary Kft.
The EMA authorised Steqeyma (ustekinumab) by Celltrion Healthcare Hungary Kft for psoriasis, psoriatic arthritis, and Crohn's disease.
-
EMA approval · 2026-04-16EMA Authorised: Qoyvolma (ustekinumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Qoyvolma (ustekinumab) by Celltrion Healthcare Hungary Kft. for psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn…
-
EMA approval · 2026-04-14EMA Authorised: Spevigo (spesolimab) — LEO Pharma A/S
The EMA authorised Spevigo (spesolimab) by LEO Pharma A/S for psoriasis, with conditional approval.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial update presents long-term safety and efficacy data for ESK-001 in adults with moderate-to-severe plaque psoriasis; the st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
A study evaluating switching from ustekinumab to guselkumab in adults with moderate-to-severe psoriasis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Psoriasis Longitudinal Assessment and Registry
This is a clinical trial update for a psoriasis longitudinal assessment and registry sponsored by Janssen. The study is currently active but…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Psoriasis Comorbidities at Hospital Calderón Guardia
A clinical trial in Costa Rica investigates psoriasis and psoriatic arthritis comorbidities, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Metabolic Profiling of Immune Responses in Immune-mediated Diseases
A clinical trial update from NIAID announces ongoing recruitment for a study investigating metabolic profiling of immune responses in immune…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Clinical, Epidemiologic, and Therapeutic Characterization of Pediatric Psoriasis in the Costa Rican Social Security System
A clinical research study characterizing pediatric psoriasis within Costa Rica's social security system; the study status is NOT_YET_RECRUIT…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Regulation of Inflammatory Genes in Psoriasis
A University of Alabama at Birmingham–sponsored clinical trial is currently recruiting to study regulation of inflammatory genes in psoriasi…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis [NA]
A clinical trial investigating intermittent fasting for psoriasis and psoriatic arthritis has completed; no results are provided in the avai…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) [Phase 1]
A Phase 1 study is evaluating the concentration of Bimzelx (bimekizumab) in mature breast milk in mothers receiving treatment, and is curren…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics [Phase 4]
Phase 4 clinical trial investigating single-cell transcriptomics to develop predictive endotypes for psoriasis treatment response. The study…